Cabozantinib most effective treatment for metastatic papillary kidney cancer

(SWOG) In a SWOG Cancer Research Network trial that put three targeted drugs to the test, the small molecule inhibitor cabozantinib was found most effective in treating patients with metastatic papillary kidney cancer - findings expected to change medical practice.
Source: EurekAlert! - Cancer - Category: Cancer & Oncology Source Type: news